Sangamo Therapeutics

Filed a patent for "zinc finger protein transcription factors for repressing nav1.7 expression" on Mon, April 17, 2023

Filed a patent for "methods for use of viral vector constructs for the treatment of fabry disease" on Mon, August 29, 2022

Filed a patent for "assays for lysosomal storage diseases" on Fri, October 14, 2022

Filed a patent for "methods and compositions for expressing phenylalanine hydroxylase" on Thu, October 12, 2023

Filed a patent for "zinc finger fusion proteins for nucleobase editing" on Thu, February 8, 2024

Filed a patent for "novel zinc finger protein transcription factors for repressing alpha-synuclein expression" on Thu, January 18, 2024

Filed a patent for "assays for fabry disease treatment" on Thu, January 4, 2024

Filed a patent for "methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (cftr) gene" on Thu, November 30, 2023

Filed a patent for "generation of cd4+ effector and regulatory t cells from human pluripotent stem cells" on Thu, December 7, 2023

Filed a patent for "improved pharmaceutical compositions containing adeno-associated viral vector" on Thu, February 29, 2024

Filed a patent for "compositions and methods for producing recombinant aav" on Thu, May 23, 2024

Filed a patent for "zinc finger protein transcription factors for treatment of prion disease" on Thu, January 5, 2023

Filed a patent for "zinc finger protein transcription factors for repressing alpha-synuclein expression" on Thu, October 13, 2022

Filed a patent for "generation of engineered regulatory t cells" on Thu, December 1, 2022

Filed a patent for "novel compositions and methods for producing recombinant aav" on Thu, January 19, 2023

Filed a patent for "zinc finger protein transcription factors for repressing tau expression" on Thu, August 3, 2023

Filed a patent for "liver-specific constructs, factor viii expression cassettes and methods of use thereof" on Thu, April 20, 2023

Filed a patent for "tau modulators and methods and compositions for delivery thereof" on Thu, August 31, 2023